U.S. Markets open in 8 hrs 25 mins
  • S&P Futures

    4,692.25
    -6.75 (-0.14%)
     
  • Dow Futures

    35,685.00
    -61.00 (-0.17%)
     
  • Nasdaq Futures

    16,374.50
    -17.75 (-0.11%)
     
  • Russell 2000 Futures

    2,262.20
    -7.60 (-0.33%)
     
  • Crude Oil

    72.99
    +0.63 (+0.87%)
     
  • Gold

    1,787.10
    +1.60 (+0.09%)
     
  • Silver

    22.47
    +0.03 (+0.15%)
     
  • EUR/USD

    1.1335
    -0.0009 (-0.0793%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • Vix

    19.90
    -1.99 (-9.09%)
     
  • GBP/USD

    1.3211
    +0.0004 (+0.0304%)
     
  • USD/JPY

    113.6000
    -0.1370 (-0.1205%)
     
  • BTC-USD

    49,801.12
    -679.69 (-1.35%)
     
  • CMC Crypto 200

    1,302.19
    -2.93 (-0.22%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • Nikkei 225

    28,773.42
    -87.20 (-0.30%)
     

2 Upcoming FDA Approval Decisions That Investors Should Really Watch

·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli discuss two upcoming U.S. Food and Drug Administration (FDA) approval decisions that investors should keep an eye on. Keith Speights: Brian, on another note, the FDA is set to make several important approval decisions in the fourth quarter. Brian Orelli: Biomarin (NASDAQ: BMRN) has one coming up on Nov. 20.